Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Palo Alto Stock Pops

Forbes · 23h
Palo Alto Networks: Buy PANW Stock At $185?
Palo Alto Networks' Debt figure was $338 Mil at the end of the most recent quarter, while its market capitalization is $132 Bil. This implies a very strong Debt-to-Equity Ratio of 0.3% (vs. 21.2% for S&P 500). [Note: A low Debt-to-Equity Ratio is desirable]
MarketWatch on MSN · 1d
Palo Alto Networks’ stock rises as earnings point to future sales boom
The cybersecurity company’s recent “platformization” push has paid off, and investors are optimistic about future growth.
Insider Monkey on MSN · 5h
Wells Fargo Reiterates Buy Rating on Palo Alto Networks, Keeps PT at $235
Palo Alto Networks, Inc. (NASDAQ:PANW) is one of the 10 Best AI Software Stocks to Buy Now. On August 15, Wells Fargo reiterated a Buy rating on Palo Alto Networks, Inc.
9h

Palo Alto Stock Pops As Analysts Say Strong Growth, CyberArk Deal Could Power Next Leg Higher

Palo Alto Networks (NASDAQ:PANW) shares are trading higher after the company beat fourth-quarter estimates and issued strong ...
1don MSN

Palo Alto's forecasts signal AI boost for cybersecurity tools, shares rise

Palo Alto Networks forecast fiscal 2026 revenue and profit above analysts' estimates on Monday, betting on growing demand for ...
21hon MSN

Palo Alto Networks receives praise from Wall Street after latest results, guidance

Palo Alto Networks (PANW) was in the spotlight on Tuesday after its latest quarterly results and guidance were ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy